Egis Gyógyszergyár Nyrt in Consumer Health (Hungary)

May 2014 | 3 pages | ID: EADBEFFA867EN
Euromonitor International Ltd

Abstracts

Egis is one of Hungary’s biggest pharmaceuticals that has a long history in Hungary. The company’s main aim to develop and produce high-quality medicines and therefore it invests a great deal in research and innovation annually. Egis also invests in supporting the activity of its 18 affiliates in the world to increase its export sales. From 2010, the company collaborated with the Korean Celltrion Pharmaceuticals to develop biological medicines.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.


Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Summary Egis Gyógyszergyár Nyrt: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Egis Gyógyszergyár Nyrt: Competitive Position 2013